LEXARIA BIOSCIENCE CORP. Prepaid Expense and Other Assets, Current
LEXARIA BIOSCIENCE CORP. (LEXX) had Prepaid Expense and Other Assets, Current of $398.76 thousand as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-07-13
- 2026-05-31: Prepaid Expense and Other Assets, Current $398.76K.
- 2026-02-28: Prepaid Expense and Other Assets, Current $458.85K.
- 2025-11-30: Prepaid Expense and Other Assets, Current $850.59K.
- 2025-08-31: Prepaid Expense and Other Assets, Current $1.13M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-05-31 | $398.76K 10-Q · filed 2026-07-13 |
| 2026-02-28 | $458.85K 10-Q · filed 2026-04-13 |
| 2025-11-30 | $850.59K 10-Q · filed 2026-01-13 |
| 2025-08-31 | $1.13M 10-Q · filed 2026-07-13 |
| 2025-05-31 | $823.35K 10-Q · filed 2025-07-14 |
| 2025-02-28 | $850.39K 10-Q · filed 2025-04-14 |
| 2024-11-30 | $444.12K 10-Q · filed 2025-01-10 |
| 2024-08-31 | $1.19M 10-K · filed 2025-11-28 |
| 2024-05-31 | $379.55K 10-Q · filed 2024-07-12 |
| 2024-02-29 | $266.80K 10-Q · filed 2024-04-09 |
| 2023-08-31 | $546.78K 10-K · filed 2024-11-26 |
| 2018-08-31 | $193.73K 10-K · filed 2018-11-14 |
| 2018-05-31 | $161.88K 10-Q · filed 2018-07-13 |
| 2018-02-28 | $176.85K 10-Q · filed 2018-04-12 |
| 2017-11-30 | $58.14K 10-Q · filed 2018-01-12 |
| 2017-08-31 | $149.69K 10-K · filed 2018-11-14 |
| 2017-05-31 | $104.52K 10-Q · filed 2017-07-14 |
| 2017-02-28 | $113.06K 10-Q · filed 2017-04-14 |
| 2016-11-30 | $143.44K 10-Q · filed 2017-01-13 |
| 2016-08-31 | $150.95K 10-K · filed 2017-11-27 |
| 2016-05-31 | $100.92K 10-Q · filed 2016-07-13 |
| 2016-02-29 | $112.07K 10-Q · filed 2016-04-13 |
| 2015-11-30 | $149.49K 10-Q · filed 2016-01-08 |
| 2015-08-31 | $215.29K 10-K · filed 2016-11-29 |
| 2015-05-31 | $224.82K 10-Q · filed 2015-07-14 |
| 2015-02-28 | $253.21K 10-Q · filed 2015-04-14 |
| 2014-11-30 | $273.25K 10-Q · filed 2015-01-14 |
| 2014-08-31 | $367.44K 10-K · filed 2015-11-27 |
| 2014-07-31 | $523.51K 10-Q · filed 2014-11-14 |
| 2014-04-30 | $414.94K 10-Q · filed 2014-06-12 |
| 2014-01-31 | $5.34K 10-Q · filed 2014-03-12 |
| 2013-10-31 | $1.51K 10-KT · filed 2014-12-09 |
| 2013-07-31 | $2.98K 10-Q · filed 2013-09-10 |
| 2013-04-30 | $4.46K 10-Q · filed 2013-06-12 |
| 2013-01-31 | $5.93K 10-Q · filed 2013-03-13 |
| 2012-10-31 | $1.48K 10-K · filed 2014-01-24 |
| 2012-07-31 | $2.95K 10-Q · filed 2012-09-12 |
| 2012-04-30 | $4.42K 10-Q · filed 2012-06-07 |
| 2012-01-31 | $5.90K 10-Q · filed 2012-03-13 |
| 2011-10-31 | $2.15K 10-K · filed 2013-01-29 |
| 2011-07-31 | $4.27K 10-Q · filed 2011-09-14 |
| 2010-10-31 | $2.34K 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |